US probes Sanofi over blockbuster drug Plavix (Update 2)
The U.S. Justice Department is investigating drug maker Sanofi's disclosures to the Food and Drug Administration about different responses to its blockbuster blood thinner Plavix.
Medications
Mar 11, 2013 |
not rated yet |
0
Pharmaceutical advertising down but not out, study says
The pharmaceutical industry has pulled back on marketing to physicians and consumers, yet some enduring patterns persist. According to a new study led by researchers at the Johns Hopkins Bloomberg School of Public Health, ...
Medications
Mar 04, 2013 |
not rated yet |
0
|
FDA Commissioner: budget cuts mean less safe food
Food and Drug Administration Commissioner Margaret Hamburg says the lack of a new 2013 budget from Congress and the upcoming across-the-board spending cuts will mean fewer food safety inspections and an increased ...
Health
Feb 28, 2013 |
not rated yet |
0
Before deciding on breast implants, consider FDA precautions
(HealthDay)—If you're thinking about getting breast implants, there are some things you need to know before you make your decision, according to the U.S. Food and Drug Administration.
Other
Feb 27, 2013 |
2.5 / 5 (2) |
1
US approves new targeted breast cancer drug (Update)
The U.S. Food and Drug Administration has approved a first-of-a-kind breast cancer medication that targets tumor cells while sparing healthy ones.
Cancer
Feb 22, 2013 |
5 / 5 (1) |
0
FDA approves new silicone gel-filled breast implant
(HealthDay)—The Natrelle 410 Highly Cohesive Anatomically Shaped Silicone-Gel Filled Breast Implant has been approved by the U.S. Food and Drug Administration for breast augmentation in women aged 22 years ...
Other
Feb 21, 2013 |
not rated yet |
0
Pomalyst approved for advanced multiple myeloma
(HealthDay)—Pomalyst (pomalidomide) has been approved by the U.S. Food and Drug Administration to treat cases of multiple myeloma that have not responded to other therapies.
Medications
Feb 09, 2013 |
not rated yet |
0
Long-term side-effects of targeted therapies in pediatric cancer patients
A University of Colorado Cancer Center review published this week in the journal Lancet Oncology describes possible long-term side-effects of new, targeted therapies in pediatric cancer patients: what we don't know may hu ...
Cancer
Feb 07, 2013 |
not rated yet |
0
US warns of new fake batch of cancer drug Avastin
The Food and Drug Administration is warning U.S. doctors about another counterfeit version of the cancer drug Avastin, the third case involving the best-selling Roche drug in the past year.
Medications
Feb 06, 2013 |
5 / 5 (1) |
0
Expert says sport and food connection too strong to ignore
Spectator sports and food—often high-calorie or low-nutrition—have long gone hand-in-hand, yet FDA regulations geared toward calorie transparency at restaurant chains ignore this relationship. Popular fast-food restaurants ...
Health
Feb 05, 2013 |
not rated yet |
0
First generic version of cancer drug Doxil approved
(HealthDay)—The first generic version of the cancer drug Doxil (doxorubicin hydrochloride liposome injection) has been approved by the U.S. Food and Drug Administration, which says the action should help relieve shortages ...
Medications
Feb 04, 2013 |
not rated yet |
0
Ravicti approved for urea cycle disorders
(HealthDay)—Ravicti (glycerol phenylbutyrate) has been approved by the U.S. Food and Drug Administration to treat certain urea cycle disorders (UCDs) in people 2 years and older.
Medications
Feb 01, 2013 |
not rated yet |
0
Researchers confirm value of flow-diverting device for most challenging aneurysms
A multi-center study supports the effectiveness of the newest technology available for the treatment of difficult, life-threatening brain aneurysms. The technology, the Pipeline embolization device, is a flow diverter that ...
Neuroscience
Jan 30, 2013 |
not rated yet |
0
FDA panel backs long-acting Boehringer inhaler
(AP)—A panel of federal health experts is overwhelmingly recommending approval for a long-acting inhaler to treat people suffering from chronic lung disease.
Medications
Jan 29, 2013 |
not rated yet |
0
Botox offers hope to women with incontinence
When most people hear Botox, they think of injections to the face to combat wrinkles and aging.
Diseases, Conditions, Syndromes
Jan 29, 2013 |
not rated yet |
0
